All In MedTech

Device Trial Radar · NCT07287436

Elite AF IDE Trial (Elite AF)

Investigational Device Evaluation of the WATCHMAN Elite™ Left Atrial Appendage Closure Technology

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Sep 18, 2026

Primary completion

Jan 2028

Study completion Nov 2032

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Dec 17, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to establish the safety and effectiveness of the WATCHMAN Elite Left Atrial Appendage Closure (LAAC) Device for subjects with non-valvular atrial fibrillation who are eligible for anticoagulation therapy to reduce the risk of stroke.

Conditions

  • Atrial Fibrillation (AF)
  • Stroke

Interventions

  • WATCHMAN Elite LAAC DeviceDevice

    WATCHMAN Elite LAAC Device Implantation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary effectiveness endpoint is the rate of effective LAA closure.Time frame: 45 days

1 more outcomes with a free account

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Arrhythmia Research Group

    Jonesboro, Arkansas · Recruiting

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.